Health Care Lobbying Rose 70% in 20 Years

Lobbying spending by the health care industries reached $713.6 million in 2020, a 70% increase over the past two decades, according to a recent JAMA Health Forum analysis based on data compiled by OpenSecrets. The growth was mainly driven by pharmaceutical and health product manufacturers and providers. Expenditures were highly concentrated among a small subset of firms, especially for payers, with the top 10% of health plans responsible for 70.4% of spending.

0 Comments
© 2022 MMIT
Jinghong Chen

Jinghong Chen Reporter

Jinghong produces infographics and data stories on health insurance and specialty pharmacy for AIS Health. She graduated from Missouri School of Journalism with a focus on data journalism and international reporting. Before joining AIS in 2018, she worked at WBEZ, Al Jazeera English and The New York Times Chinese.

Related Posts

us-capitol
February 24

Pharma Industry Spent Big to Block Drug Price Reform in 2021

READ MORE
post-default-image
September 24

Pharma Industry Spends Big on Lobbying Amid COVID-19, Upcoming Election

Read More
businessmen-shaking-hands
November 18

Payer Lobbying May Pale Next to Pharma, but Experts Say Industry Still Packs Clout

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today